Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Other Gross PP&E Adjustments (2020 - 2025)

Cytek Biosciences' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at $13.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 15.66% year-over-year to $13.9 million; the TTM value through Dec 2025 reached $13.9 million, up 15.66%, while the annual FY2025 figure was $13.9 million, 15.66% up from the prior year.
  • Other Gross PP&E Adjustments reached $13.9 million in Q4 2025 per CTKB's latest filing, down from $16.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $16.0 million in Q3 2025 to a low of -$6.0 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $7.5 million, with a median of $9.7 million recorded in 2025.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 271.23% in 2022, then skyrocketed 646.45% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $6.6 million in 2021, then tumbled by 79.07% to $1.4 million in 2022, then surged by 646.45% to $10.3 million in 2023, then rose by 16.83% to $12.0 million in 2024, then grew by 15.66% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Other Gross PP&E Adjustments are $13.9 million (Q4 2025), $16.0 million (Q3 2025), and $9.7 million (Q2 2025).